We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+14.27%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$256M
AUM Growth
+$12.2M
Cap. Flow
-$14.2M
Cap. Flow %
-5.52%
Top 10 Hldgs %
47.16%
Holding
248
New
79
Increased
35
Reduced
67
Closed
65

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.6M
2
EOG icon
EOG Resources
EOG
+$2.56M
3
CVX icon
Chevron
CVX
+$2.51M
4
KVUE icon
Kenvue
KVUE
+$1.8M
5
NEE icon
NextEra Energy
NEE
+$1.79M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$3M
2
PPG icon
PPG Industries
PPG
+$2.06M
3
CL icon
Colgate-Palmolive
CL
+$1.74M
4
MCD icon
McDonald's
MCD
+$1.67M
5
RTX icon
RTX Corp
RTX
+$1.53M

Sector Composition

Rank Sector Weight
1 Technology 17.66%
2 Financials 12.3%
3 Healthcare 9.54%
4 Energy 5.49%
5 Consumer Staples 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZS icon
51
Zscaler
ZS
$28.9B
$905K 0.35%
4,085
-1,194
-23% -$221K
DKNG icon
52
DraftKings
DKNG
$12.6B
$905K 0.35%
+25,675
New +$859K
ALNY icon
53
Alnylam Pharmaceuticals
ALNY
$29.6B
$903K 0.35%
+4,720
New +$804K
MANH icon
54
Manhattan Associates
MANH
$11.4B
$893K 0.35%
4,148
+2,967
+251% +$628K
INTC icon
55
Intel
INTC
$493B
$889K 0.35%
17,693
-5,608
-24% -$228K
VRT icon
56
Vertiv
VRT
$108B
$864K 0.34%
+17,999
New +$766K
ELV icon
57
Elevance Health
ELV
$84.7B
$858K 0.33%
1,819
-2,919
-62% -$1.35M
PFE icon
58
Pfizer
PFE
$152B
$831K 0.32%
28,879
-1,435
-5% -$43.4K
CME icon
59
CME Group
CME
$93.2B
$820K 0.32%
+3,896
New +$831K
PGR icon
60
Progressive
PGR
$123B
$819K 0.32%
+5,139
New +$805K
CI icon
61
Cigna
CI
$72.4B
$817K 0.32%
2,728
-3,345
-55% -$978K
ALL icon
62
Allstate
ALL
$66.3B
$816K 0.32%
+5,829
New +$760K
WTW icon
63
Willis Towers Watson
WTW
$31.8B
$815K 0.32%
+3,378
New +$781K
SNOW icon
64
Snowflake
SNOW
$116B
$811K 0.32%
+4,074
New +$689K
DXCM icon
65
DexCom
DXCM
$33.8B
$803K 0.31%
+6,468
New +$661K
NTAP icon
66
NetApp
NTAP
$38.9B
$802K 0.31%
+9,102
New +$733K
HWM icon
67
Howmet Aerospace
HWM
$112B
$801K 0.31%
+14,806
New +$730K
COIN icon
68
Coinbase
COIN
$39.2B
$797K 0.31%
+4,584
New +$501K
VRTX icon
69
Vertex Pharmaceuticals
VRTX
$134B
$792K 0.31%
+1,947
New +$719K
MU icon
70
Micron Technology
MU
$981B
$791K 0.31%
+9,269
New +$689K
DDOG icon
71
Datadog
DDOG
$88.6B
$784K 0.31%
+6,461
New +$665K
XYZ
72
Block Inc
XYZ
$47.5B
$784K 0.31%
+10,132
New +$573K
HES
73
DELISTED
Hess
HES
$783K 0.31%
+5,431
New +$796K
MDB icon
74
MongoDB
MDB
$35.3B
$772K 0.3%
1,887
-395
-17% -$150K
META icon
75
Meta Platforms (Facebook)
META
$1.53T
$680K 0.27%
1,920
-2,682
-58% -$873K

Similar funds

Alpha DNA Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Alpha DNA Investment Management held 248 positions worth $256M, up 5% from $244M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Alpha DNA Investment Management withdrew a net $14.2M in Q4 2023, closing 65 positions and reducing 67 holdings. Its most notable exit was Eli Lilly, an estimated $3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Alpha DNA Investment Management opened a new position in Kenvue worth $1.93M.

  • Alpha DNA Investment Management's largest Q4 2023 buy was Kenvue: 89,868 shares worth $1.93M.
  • Alpha DNA Investment Management added most to Microsoft in Q4 2023, an estimated $2.6M increase.
  • Alpha DNA Investment Management's biggest Q4 2023 reduction was PPG Industries, cutting an estimated $2.06M.
  • Alpha DNA Investment Management fully exited Eli Lilly in Q4 2023, selling an estimated $3M.
  • Alpha DNA Investment Management's ten largest holdings make up 47% of its $256M portfolio in Q4 2023.
  • Alpha DNA Investment Management opened 79 new positions and closed 65 in Q4 2023.
  • Alpha DNA Investment Management's portfolio value rose 5% quarter-over-quarter to $256M.

Based on Alpha DNA Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.